S3854Temporary National Codes (Non-Medicare)
Gene expression profiling panel for use in the management of breast cancer
Short description: Gene profile panel breast
- Effective date
- July 1, 2016
- Termination date
- —
Related codes (S-series)
S0012Butorphanol tartrate, nasalS0013Esketamine, nasal sprayS0014Tacrine hydrochloride, 10 mgS0017Injection, aminocaproic acidS0020Injection, bupivicaine hydroS0021Injection, cefoperazone sodS0023Injection, cimetidine hydrocS0028Injection, famotidine, 20 mgS0030Injection, metronidazoleS0032Injection, nafcillin sodiumS0034Injection, ofloxacin, 400 mgS0039Injection, sulfamethoxazole
Frequently asked questions
What is HCPCS code S3854?
S3854 is a HCPCS Level II code for Gene expression profiling panel for use in the management of breast cancer.
What category is HCPCS code S3854 in?
S3854 falls under the Temporary National Codes (Non-Medicare) category of HCPCS Level II.
When did HCPCS code S3854 become effective?
S3854 has been effective since July 1, 2016, per CMS's quarterly HCPCS update.
HCPCS Level II data from CMS (public domain). HCPCS Level I (CPT) codes are not included — CPT is copyrighted by the American Medical Association. Always verify codes with authoritative sources before making coding or billing decisions.